Literature DB >> 19923220

Unraveling of the E-helices and disruption of 4-fold pores are associated with iron mishandling in a mutant ferritin causing neurodegeneration.

Martin A Baraibar1, Barry B Muhoberac, Holly J Garringer, Thomas D Hurley, Ruben Vidal.   

Abstract

Mutations in the coding sequence of the ferritin light chain (FTL) gene cause a neurodegenerative disease known as neuroferritinopathy or hereditary ferritinopathy, which is characterized by the presence of intracellular inclusion bodies containing the mutant FTL polypeptide and by abnormal accumulation of iron in the brain. Here, we describe the x-ray crystallographic structure and report functional studies of ferritin homopolymers formed from the mutant FTL polypeptide p.Phe167SerfsX26, which has a C terminus that is altered in amino acid sequence and length. The structure was determined and refined to 2.85 A resolution and was very similar to the wild type between residues Ile-5 and Arg-154. However, instead of the E-helices normally present in wild type ferritin, the C-terminal sequences of all 24 mutant subunits showed substantial amounts of disorder, leading to multiple C-terminal polypeptide conformations and a large disruption of the normally tiny 4-fold axis pores. Functional studies underscored the importance of the mutant C-terminal sequence in iron-induced precipitation and revealed iron mishandling by soluble mutant FTL homopolymers in that only wild type incorporated iron when in direct competition in solution with mutant ferritin. Even without competition, the amount of iron incorporation over the first few minutes differed severalfold. Our data suggest that disruption at the 4-fold pores may lead to direct iron mishandling through attenuated iron incorporation by the soluble form of mutant ferritin and that the disordered C-terminal polypeptides may play a major role in iron-induced precipitation and formation of ferritin inclusion bodies in hereditary ferritinopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923220      PMCID: PMC2804353          DOI: 10.1074/jbc.M109.042986

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement.

Authors:  P Maciel; V T Cruz; M Constante; I Iniesta; M C Costa; S Gallati; N Sousa; J Sequeiros; P Coutinho; M M Santos
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

Review 2.  Ferritins: iron/oxygen biominerals in protein nanocages.

Authors:  Elizabeth C Theil; Manolis Matzapetakis; Xiaofeng Liu
Journal:  J Biol Inorg Chem       Date:  2006-07-26       Impact factor: 3.358

3.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.

Authors:  A R Curtis; C Fey; C M Morris; L A Bindoff; P G Ince; P F Chinnery; A Coulthard; M J Jackson; A P Jackson; D P McHale; D Hay; W A Barker; A F Markham; D Bates; A Curtis; J Burn
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

4.  Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene.

Authors:  E Ohta; T Nagasaka; K Shindo; S Toma; K Nagasaka; K Ohta; Z Shiozawa
Journal:  Neurology       Date:  2008-04-15       Impact factor: 9.910

5.  Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene.

Authors:  Ana G Barbeito; Holly J Garringer; Martin A Baraibar; Xiaoying Gao; Miguel Arredondo; Marco T Núñez; Mark A Smith; Bernardino Ghetti; Ruben Vidal
Journal:  J Neurochem       Date:  2009-03-30       Impact factor: 5.372

6.  Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice.

Authors:  Ruben Vidal; Leticia Miravalle; Xiaoying Gao; Ana G Barbeito; Martin A Baraibar; Shahryar K Hekmatyar; Mario Widel; Navin Bansal; Marie B Delisle; Bernardino Ghetti
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

7.  A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations.

Authors:  Akatsuki Kubota; Ayumi Hida; Yaeko Ichikawa; Yoshio Momose; Jun Goto; Yukifusa Igeta; Hideji Hashida; Kunihiro Yoshida; Syu-Ichi Ikeda; Ichiro Kanazawa; Shoji Tsuji
Journal:  Mov Disord       Date:  2009-02-15       Impact factor: 10.338

8.  Mutations of ferritin H chain C-terminus produced by nucleotide insertions have altered stability and functional properties.

Authors:  Rosaria Ingrassia; Gianmario Gerardi; Giorgio Biasiotto; Paolo Arosio
Journal:  J Biochem       Date:  2006-05       Impact factor: 3.387

9.  Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation.

Authors:  David Devos; P Jissendi Tchofo; Isabelle Vuillaume; Alain Destée; Stephanie Batey; John Burn; Patrick F Chinnery
Journal:  Brain       Date:  2008-10-14       Impact factor: 13.501

10.  Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration.

Authors:  Martin A Baraibar; Ana G Barbeito; Barry B Muhoberac; Ruben Vidal
Journal:  J Biol Chem       Date:  2008-08-28       Impact factor: 5.157

View more
  23 in total

Review 1.  The neuropathology of neurodegeneration with brain iron accumulation.

Authors:  Michael C Kruer
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

2.  Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons.

Authors:  Jozsef Gal; Jing Chen; Yuriko Katsumata; David W Fardo; Wang-Xia Wang; Sergey Artiushin; Douglas Price; Sonya Anderson; Ela Patel; Haining Zhu; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

Review 3.  A possible role for secreted ferritin in tissue iron distribution.

Authors:  Esther G Meyron-Holtz; Shirly Moshe-Belizowski; Lyora A Cohen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-06       Impact factor: 3.575

4.  Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro.

Authors:  Erin K Stachowski; Robert Schwarcz
Journal:  J Neural Transm (Vienna)       Date:  2011-08-11       Impact factor: 3.575

5.  Sub-3 Å apoferritin structure determined with full range of phase shifts using a single position of volta phase plate.

Authors:  Kunpeng Li; Chen Sun; Thomas Klose; Jose Irimia-Dominguez; Frank S Vago; Ruben Vidal; Wen Jiang
Journal:  J Struct Biol       Date:  2019-03-27       Impact factor: 2.867

6.  A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage.

Authors:  Martin A Baraibar; Ana G Barbeito; Barry B Muhoberac; Ruben Vidal
Journal:  Free Radic Biol Med       Date:  2012-02-17       Impact factor: 7.376

Review 7.  Pathogenic mechanism and modeling of neuroferritinopathy.

Authors:  Anna Cozzi; Paolo Santambrogio; Maddalena Ripamonti; Ermanna Rovida; Sonia Levi
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

Review 8.  Iron metabolism in the CNS: implications for neurodegenerative diseases.

Authors:  Tracey A Rouault
Journal:  Nat Rev Neurosci       Date:  2013-07-03       Impact factor: 34.870

9.  Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy.

Authors:  Ana G Barbeito; Thierry Levade; Marie B Delisle; Bernardino Ghetti; Ruben Vidal
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

10.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.